Market Cap (In KRW)
187.69 Billion
Revenue (In KRW)
224.45 Billion
Net Income (In KRW)
22.33 Billion
Avg. Volume
21.13 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10120.0-14940.0
- PE
- -
- EPS
- -
- Beta Value
- 0.474651
- ISIN
- KR7293480000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Taehong Choi
- Employee Count
- -
- Website
- https://www.hanaph.co.kr
- Ipo Date
- 2018-10-02
- Details
- Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.
More Stocks
-
0412
-
RSSS
-
ENELCHILEEnel Chile S.A.
ENELCHILE
-
3878Tomoegawa Co., Ltd.
3878
-
420770GigaVis Co., Ltd.
420770
-
MMM3M Company
MMM
-
603699
-
5007